Long-Term Outcomes for Lumbar Spinal Stenosis Patients Treated With X STOP®



Status:Completed
Conditions:Orthopedic
Therapuetic Areas:Orthopedics / Podiatry
Healthy:No
Age Range:50 - Any
Updated:1/3/2018
Start Date:December 2006
End Date:June 2010

Use our guide to learn which trials are right for you!

Long-term Outcomes Among Patients With Lumbar Spinal Stenosis Treated With the X STOP® Interspinous Process Decompression System: Five-Year Follow-up of IDE Patient Cohorts

The Long-Term Outcomes Study (LTOS) is a multi-center longitudinal cohort study of all
patients who received the X-STOP device in the Pivotal Trial, Continued Access Protocol
(CAP), or Cross-over Study (COS). It is designed to supplement postmarket safety and
effectiveness data to be gathered in a Condition of Approval (CoA) study of a population of
patients with moderately impaired physical function who elect to undergo X-STOP surgery.

Evaluate the long term safety and effectiveness of the X-Stop interspinous process
decompression system In the patients who received the X-Stop under the IDE. These patients
consist of two cohorts to be evaluated: patients who had moderately impaired physical
function prior to X-Stop implantation (as determined by a baseline score >2.0 in the physical
function (PF) domain of the Zurich claudication questionnaire), and patients who had mildly
impaired physical function prior to X-Stop surgery(as determined by a baseline score <=2.0 in
the PF domain of the Zurich claudication questionnaire (ZCQ), through the fifth postoperative
year. Clinical examination will be performed at each office visit to confirm the absence of
neurological complications. X-ray films (AP/lateral views) taken during the fifth
postoperative year will, be analyzed to confirm A) maintenance of distraction and B) the
absence of radiological evidence of device-related complications. Secondary endpoints will
include mean scores from the SF-36, and incidence rates of adverse events, device failures,
and secondary surgeries.

Inclusion Criteria:

A patient will be admitted into the LTOS program if he/she meets all of the following
inclusion criteria:

1. Completed participation in the Pivotal Trial, CAP, or COS and has the X STOP
implant(s) intact at the time of LTOS enrollment; OR is an active CAP/COS participant,
has the X STOP implant(s) intact, and has not completed a 24-month follow-up visit in
his/her CAP/COS study.

2. Is willing and able to provide Informed Consent

3. Is willing and able to return to the clinic for a clinical evaluation or complete
study questionnaires without a clinic visit.

Exclusion Criteria:

A patient will not be admitted into the LTOS program if he/she meets any of the following
exclusion criteria:

1. Participated in the Pivotal Trial as part of the X STOP group, but the device has been
removed.

2. Participated in the CAP or COS programs, but the device has been removed.
We found this trial at
5
sites
600 Highland Avenue
Madison, Wisconsin 53792
?
mi
from
Madison, WI
Click here to add this to my saved trials
301 Riverview Avenue
Norfolk, Virginia 23510
?
mi
from
Norfolk, VA
Click here to add this to my saved trials
San Francisco, California 94117
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
49 Spring Street
Scarborough, Maine 04074
?
mi
from
Scarborough, ME
Click here to add this to my saved trials
Timonium, Maryland 21093
?
mi
from
Timonium, MD
Click here to add this to my saved trials